Jimmy Shen
Overview
Explore the profile of Jimmy Shen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Bell D, Carroll R, Chiang C, Cowley D, Croker E, et al.
Clin Endocrinol (Oxf)
. 2024 Oct;
102(1):31-43.
PMID: 39360599
Adrenal vein sampling (AVS) is the current recommended procedure for identifying unilateral subtypes of primary aldosteronism (PA), which are amenable to surgery with the potential for cure. AVS is a...
2.
Yang J, McCarthy J, Shah S, Ng E, Shen J, Libianto R, et al.
J Endocr Soc
. 2024 Jun;
8(7):bvae109.
PMID: 38887633
Primary aldosteronism, characterized by the dysregulated production of aldosterone from 1 or both adrenal glands, is the most common endocrine cause of hypertension. It confers a high risk of cardiovascular,...
3.
Hashimura H, Hu J, Kobayashi H, Gwini S, Shen J, Chee N, et al.
Eur J Endocrinol
. 2023 Jan;
188(1).
PMID: 36651157
Objectives: The saline suppression test (SST) serves to confirm the diagnosis of primary aldosteronism (PA), while adrenal vein sampling (AVS) is used to subtype PA as unilateral or bilateral. Criteria...
4.
Solanki P, Gwini S, Libianto R, Gabb G, Shen J, Young M, et al.
BMJ Open
. 2022 Nov;
12(11):e062406.
PMID: 36375972
Objectives: Primary aldosteronism (PA), the most common endocrine cause of hypertension, is associated with a higher risk of cardiovascular disease (CVD) than blood pressure (BP)-matched essential hypertension (EH). We aimed...
5.
Ng E, Gwini S, Libianto R, Choy K, Lu Z, Shen J, et al.
J Clin Endocrinol Metab
. 2022 Sep;
108(1):33-41.
PMID: 36179243
Context: The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio (ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual variability of PAC and ARR using plasma renin activity...
6.
Zhang J, Yang J, Libianto R, Shen J, Fuller P, Grodski S, et al.
Surgery
. 2022 Sep;
172(6):1682-1688.
PMID: 36123178
Background: Primary aldosteronism is the most common surgically curable cause of endocrine hypertension. Management of the unilateral subtype of primary aldosteronism with adrenalectomy requires multidisciplinary input. It is unclear if...
7.
Yang J, Libianto R, Lau K, Doery J, Wan K, Chee N, et al.
Radiology
. 2022 May;
304(3):716-718.
PMID: 35608441
See also the editorial by Georgiades in this issue.
8.
Libianto R, Russell G, Stowasser M, Gwini S, Nuttall P, Shen J, et al.
Med J Aust
. 2022 Feb;
216(8):408-412.
PMID: 35218017
Objective: To assess the identification of primary aldosteronism (PA) in newly diagnosed, treatment-naïve patients with hypertension by screening in primary care. Design: Prospective study. Setting: General practices in the South...
9.
Zhang J, Libianto R, Lee J, Grodski S, Shen J, Fuller P, et al.
Clin Endocrinol (Oxf)
. 2021 Nov;
96(1):40-46.
PMID: 34743353
Background: The preoperative use of mineralocorticoid receptor antagonists (MRA) in patients with unilateral forms of primary aldosteronism (PA) is not standardized. The current Endocrine Society Guidelines do not specifically recommend...
10.
Libianto R, Menezes S, Kaur A, Gwini S, Shen J, Narayan O, et al.
Clin Endocrinol (Oxf)
. 2020 Dec;
94(3):353-360.
PMID: 33270939
Objective: Primary aldosteronism (PA) is a potentially curable cause of hypertension associated with worse cardiovascular prognosis than blood pressure-matched essential hypertension (EH). Effective targeted treatment for PA is available with...